Hodayat Haaretz Ltd.

TASE:HDHA-M Stock Report

Market Cap: ₪21.0m

Hodayat Haaretz (HDHA-M) Stock Overview

Operates as a medical device company. More details

HDHA-M fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health0/6
Dividends0/6

Rewards

Price-To-Earnings ratio (1.5x) is below the IL market (15.3x)

Became profitable this year

Risk Analysis

Negative shareholders equity

Debt is not well covered by operating cash flow

Shares are highly illiquid

Makes less than USD$1m in revenue (₪1M)

+ 3 more risks

HDHA-M Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
48.7% undervalued intrinsic discount
59.20%
Revenue growth p.a.
7users have liked this narrative
0users have commented on this narrative
39users have followed this narrative
25 days ago author updated this narrative

Hodayat Haaretz Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Hodayat Haaretz
Historical stock prices
Current Share Price₪17.58
52 Week High₪18.00
52 Week Low₪15.00
Beta-0.096
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Change-91.38%
5 Year Changen/a
Change since IPO-96.54%

Recent News & Updates

Recent updates

We're Keeping An Eye On ENvizion Medical's (TLV:ENVM) Cash Burn Rate

Oct 19
We're Keeping An Eye On ENvizion Medical's (TLV:ENVM) Cash Burn Rate

Shareholder Returns

HDHA-MIL Medical EquipmentIL Market
7Dn/a7.5%1.2%
1Yn/a35.4%61.9%

Return vs Industry: Insufficient data to determine how HDHA-M performed against the IL Medical Equipment industry.

Return vs Market: Insufficient data to determine how HDHA-M performed against the IL Market.

Price Volatility

Is HDHA-M's price volatile compared to industry and market?
HDHA-M volatility
HDHA-M Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.9%
Market Average Movement5.3%
10% most volatile stocks in IL Market8.1%
10% least volatile stocks in IL Market3.6%

Stable Share Price: HDHA-M's share price has been volatile over the past 3 months compared to the IL market.

Volatility Over Time: Insufficient data to determine HDHA-M's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/aDoron Besserwww.envizionmed.com

Hodayat Haaretz Ltd. operates as a medical device company. It offers ENvue feeding tube placement system that utilizes the methods of navigation, integrated sensors, and body mapping to provide feeding tube placement. The company was formerly known as ENvizion Medical Ltd.

Hodayat Haaretz Ltd. Fundamentals Summary

How do Hodayat Haaretz's earnings and revenue compare to its market cap?
HDHA-M fundamental statistics
Market cap₪21.02m
Earnings (TTM)₪13.70m
Revenue (TTM)₪1.22m
1.5x
P/E Ratio
17.2x
P/S Ratio

Is HDHA-M overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HDHA-M income statement (TTM)
Revenue₪1.22m
Cost of Revenue₪59.00k
Gross Profit₪1.16m
Other Expenses-₪12.54m
Earnings₪13.70m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)11.50
Gross Margin95.15%
Net Profit Margin1,126.48%
Debt/Equity Ratio-87.9%

How did HDHA-M perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/30 20:36
End of Day Share Price 2025/06/30 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hodayat Haaretz Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.